PROTEIN SCIENCE IN DRUG DISCOVERY 2022
The 2022 Protein Science in Drug Discovery ELRIG meeting will be held at AstraZeneca, Cambridge UK. The meeting will host leading scientists from industry and academia and will aim to focus on the application of emerging areas of Protein Science to the challenges of modern drug discovery. The interactive 2-day event will include 4 sessions. The sequential sessions will cover high throughput methods for protein expression, approaches for prosecuting challenging target space and analytical techniques to interrogate protein quality. In addition, AI tools for the development of methods to predict protein production will be discussed. Join scientists from academia, pharma, biotech and CRO´s to hear cutting-edge science, network and visit the vendor booths.
- High-throughput approaches for protein expression Session Chairs Maja Firczuk GlaxoSmithKline and Hanna Tegel KTH. Processes for generating expression constructs, automation and miniaturizations of screening methods
- Advancement in protein production of novel and challenging soluble targets Session Chairs Panchali Goswami GSK and Valerie Pye The Francis Crick Institute. Historically challenging targets, protein complexes and novel target space
- Prosecution of membrane protein targets Session Chairs Arjan Snijder AstraZeneca and Maria Marta Garcia Alai EMBL.
- Accelerate protein production with the development of AI techniques Session Chairs Aurelie Bornot AstraZeneca and Brian Marsden University of Oxford. Recent advancement in machine learning show promise for predicting protein yields and protein structure